A recent clinical trial has shown that aspirin/phosphatidylcholine has demonstrated bioequivalence with regular aspirin.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1644, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A trial to assess the clinical mechanistics of aspirin in healthy volunteers

By J G.   P M.   A H.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 5, 2002-10 ,pp. : 203-207

Adis International

Access to resources Recommend Favorite

Regular aspirin use linked with macular degeneration

By  

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Individual bioequivalence-has its time come?

By Endrenyi L.   Midha K.K.  

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 4, 1998-10 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Urocortin has demonstrated potential as a treatment for heart disease

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Augmentation of Citalopram with Aspirin for Treating Major Depressive Disorder, a Double Blind Randomized Placebo Controlled Clinical Trial

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 2, 2014-08 ,pp. : 108-111

Bentham Science Publishers

Access to resources Recommend Favorite